1. Anti-Müllerian hormone in breast cancer patients treated with chemotherapy: a retrospective evaluation of subsequent pregnancies 
Anne-Sophie Hamy, Raphaël Porcher, Sarah Eskenazi, Caroline Cuvier, Sylvie Giacchetti, Florence Coussy, Hamid Hocini, Bertrand Tournant, Francine Perret, Sylvie Bonfils, Patrick Charvériat, Jean-Marc Lacorte, Marc Espie 
Reproductive BioMedicine Online 
Volume 32, Issue 3, Pages (March 2016)
DOI: /j.rbmo
Copyright © 2015 Reproductive Healthcare Ltd. Terms and Conditions

2. Figure 1
Serum anti-Müllerian hormone (AMH) concentrations in women with subsequent pregnancy. The blue points represent AMH assays (log scale, ng/ml) as a function of time since last chemotherapy (years). The horizontal grey line shows the limit of detection of AMH according to the manufacturer (0.14 ng/ml). The black arrows represent the beginning of each pregnancy.
Reproductive BioMedicine Online  , DOI: ( /j.rbmo )
Copyright © 2015 Reproductive Healthcare Ltd. Terms and Conditions